Bio-Rad Laboratories (BIO.B) Competitors $334.85 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends BIO.B vs. KEYS, FTV, VLTO, TER, RVTY, AVTR, VNT, NVMI, ST, and MIRShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Vontier (VNT), Nova (NVMI), Sensata Technologies (ST), and Mirion Technologies (MIR). These companies are all part of the "measuring and control equipment" industry. Bio-Rad Laboratories vs. Keysight Technologies Fortive Veralto Teradyne Revvity Avantor Vontier Nova Sensata Technologies Mirion Technologies Keysight Technologies (NYSE:KEYS) and Bio-Rad Laboratories (NYSE:BIO.B) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, community ranking, valuation and institutional ownership. Is KEYS or BIO.B more profitable? Keysight Technologies has a net margin of 12.32% compared to Bio-Rad Laboratories' net margin of -30.18%. Keysight Technologies' return on equity of 19.34% beat Bio-Rad Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Keysight Technologies12.32% 19.34% 10.56% Bio-Rad Laboratories -30.18%3.74%2.65% Do analysts recommend KEYS or BIO.B? Keysight Technologies currently has a consensus price target of $177.30, suggesting a potential upside of 7.14%. Given Keysight Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Keysight Technologies is more favorable than Bio-Rad Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Keysight Technologies 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Bio-Rad Laboratories 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in KEYS or BIO.B? Keysight Technologies received 346 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. Likewise, 66.06% of users gave Keysight Technologies an outperform vote while only 57.60% of users gave Bio-Rad Laboratories an outperform vote. CompanyUnderperformOutperformKeysight TechnologiesOutperform Votes47166.06% Underperform Votes24233.94% Bio-Rad LaboratoriesOutperform Votes12557.60% Underperform Votes9242.40% Which has more risk and volatility, KEYS or BIO.B? Keysight Technologies has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Which has better valuation & earnings, KEYS or BIO.B? Keysight Technologies has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Keysight Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKeysight Technologies$4.98B5.77$1.06B$3.5047.28Bio-Rad Laboratories$2.67B3.51-$637.32M-$27.33-12.25 Does the media refer more to KEYS or BIO.B? In the previous week, Keysight Technologies had 52 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 52 mentions for Keysight Technologies and 0 mentions for Bio-Rad Laboratories. Keysight Technologies' average media sentiment score of 0.79 beat Bio-Rad Laboratories' score of 0.00 indicating that Keysight Technologies is being referred to more favorably in the media. Company Overall Sentiment Keysight Technologies Positive Bio-Rad Laboratories Neutral Do insiders & institutionals believe in KEYS or BIO.B? 84.6% of Keysight Technologies shares are owned by institutional investors. Comparatively, 0.0% of Bio-Rad Laboratories shares are owned by institutional investors. 0.6% of Keysight Technologies shares are owned by insiders. Comparatively, 28.4% of Bio-Rad Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryKeysight Technologies beats Bio-Rad Laboratories on 17 of the 18 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO.B vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$9.38B$5.07B$5.06B$19.88BDividend YieldN/A0.46%5.18%3.52%P/E Ratio-12.2523.87126.3142.94Price / Sales3.514.391,178.7419.18Price / Cash27.6640.7033.8617.86Price / Book1.092.084.685.52Net Income-$637.32M$515,312.50$119.54M$986.45M7 Day PerformanceN/A-5.56%-1.83%0.45%1 Month PerformanceN/A-8.12%-3.60%1.05%1 Year Performance11.58%-17.04%31.91%24.67% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIO.BBio-Rad LaboratoriesN/A$334.85flatN/A+11.6%$9.38B$2.67B-12.258,200KEYSKeysight Technologies4.5709 of 5 stars$166.29+0.5%$177.30+6.6%+22.7%$28.86B$4.98B47.2814,900Analyst ForecastOptions VolumeNews CoverageFTVFortive4.8974 of 5 stars$75.95+0.3%$87.82+15.6%+11.9%$26.35B$6.07B30.1818,000Analyst ForecastVLTOVeralto2.4877 of 5 stars$105.35+0.2%$108.27+2.8%+48.5%$26.05B$5.02B32.4416,000Positive NewsTERTeradyne4.9942 of 5 stars$104.25+0.6%$142.62+36.8%+11.3%$16.98B$2.68B32.886,500Buyback AnnouncementPositive NewsRVTYRevvity3.9818 of 5 stars$113.14+1.6%$132.07+16.7%+26.4%$13.77B$2.75B53.7911,500Positive NewsAVTRAvantor4.9762 of 5 stars$20.02-0.6%$27.57+37.7%+3.6%$13.63B$6.97B43.7814,500Analyst RevisionVNTVontier3.599 of 5 stars$37.92+1.4%$44.50+17.4%+10.9%$5.70B$3.10B14.338,000NVMINova4.097 of 5 stars$178.24+2.3%$227.80+27.8%+43.1%$5.18B$517.92M32.503,606Positive NewsSTSensata Technologies4.8577 of 5 stars$30.89+0.6%$41.00+32.7%-4.9%$4.62B$4.05B-56.9119,400Positive NewsMIRMirion Technologies1.507 of 5 stars$16.08+0.1%$16.00-0.5%+82.0%$3.73B$800.90M-47.283,000 Related Companies and Tools Related Companies KEYS Competitors FTV Competitors VLTO Competitors TER Competitors RVTY Competitors AVTR Competitors VNT Competitors NVMI Competitors ST Competitors MIR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BIO.B) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO.B Stock Alerts